Pharmena S.A. (WSE:PHR)

Poland flag Poland · Delayed Price · Currency is PLN
3.100
-0.050 (-1.59%)
Mar 3, 2026, 5:00 PM CET
-30.96%
Market Cap 35.08M
Revenue (ttm) 1.58M
Net Income (ttm) -2.77M
Shares Out 11.14M
EPS (ttm) -0.25
PE Ratio n/a
Forward PE n/a
Dividend 0.85 (26.98%)
Ex-Dividend Date n/a
Volume 4,542
Average Volume 3,588
Open 3.150
Previous Close 3.150
Day's Range 3.010 - 3.170
52-Week Range 2.500 - 4.700
Beta 0.79
RSI 36.00
Earnings Date Feb 23, 2026

About Pharmena

Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including face, hair, and body care products, as well as dietary supplement. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 7
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PHR
Full Company Profile

Financial Performance

In 2025, Pharmena's revenue was 1.58 million, an increase of 488.43% compared to the previous year's 268,000. Losses were -2.77 million, 119.4% more than in 2024.

Financial Statements

News

There is no news available yet.